Adjunctive rifampicin to reduce early mortality from <it>Staphylococcus aureus</it> bacteraemia (ARREST): study protocol for a randomised controlled trial
<p>Abstract</p> <p>Background</p> <p><it>Staphylococcus aureus</it> bacteraemia is a common and serious infection, with an associated mortality of ~25%. Once in the blood, <it>S. aureus</it> can disseminate to infect almost any organ, but bones, joints and heart valves are most frequently affected....
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2012-12-01
|
| Ráidu: | Trials |
| Fáttát: | |
| Liŋkkat: | http://www.trialsjournal.com/content/13/1/241 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
